Showing 11-20 of 2501 results for "".
Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-amyloid-pet-tests-for-alzheimer-disease/37135/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of amyloid PET tests for Alzheimer disease.INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
https://practicalneurology.com/diseases-diagnoses/movement-disorders/intrepid-subthalamic-nucleus-deep-brain-stimulation-parkinson-disease/48741/Jerrold L. Vitek, MD, PhD, Head of the Neurology Department at the University of Minnesota, Minneapolis, MN, provides an overview of the INTREPID clinical trial which assessed subthalamic nucleus deep brain stimulation in patients with Parkinson disease.How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
https://practicalneurology.com/videos/neurology-in-motion/how-to-communicate-the-results-of-alzheimer-disease-biomarker-tests-with-patients/39733/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the results of Alzheimer disease biomarker tests with patients.Factors Influencing the Selection of Blood Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-blood-tests-for-alzheimer-disease/39224/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of blood tests for Alzheimer disease.New Guidelines for the Assessment of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/new-guidelines-for-the-assessment-of-traumatic-brain-injury/35727/Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, the University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testinAdvances in the Evaluation of TBI
https://practicalneurology.com/diseases-diagnoses/tbi/advances-in-the-evaluation-of-tbi/30093/Welcome to Neurology: Disease Deep Dive. In this episode, Dr. Beth McQuiston, MD, RD, Medical Director at Abbott Laboratories, and Dr. David Okonkwo, MD, PhD, Professor of Neurological Surgery, Clinical Director of the Brain Trauma Research Center, and Director of the Neurotrauma Program at Universi- Dementia and Driving: When Should You Put on the Brakes?https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0606DrivingFea-pdf/31302/In the June 2006 issue of *Practical Neurology*, Heather Tuckman, PsyD, John Gordon, PhD, Steven Mandel, MD, and Edward Maitz, PhD explore the critical intersection between dementia and driving safety, illustrated through the case of Harold. Harold exhibited troubling behaviors, such as hiding keys
Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/detecting-multiple-sclerosis-earlier-prls-and-the-evolving-mcdonald-diagnostic-criteria/54390/This episode explores new evidence showing that paramagnetic rim lesions (PRLs) are highly prevalent early in multiple sclerosis (MS) and can differentiate MS from mimics with striking accuracy. Daniel Ontaneda, MD, PhD, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, and Pascal Sati, PhSMA Experience: Episode 2
https://practicalneurology.com/diseases-diagnoses/neuromuscular/sma-experience-episode-2/30081/Neuromusclar disease expert Diana Bharucha-Goebel, MD, PhD chats with Traci High, mother of two patients with SMA about how the SMA treatment landscape, and her childens' lives, have changed over the past 15 years.Biomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their p